CRIS Curis, Inc. - Common Stock

NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗
$1,88
Prezzo · Ago 18, 2026
Fondamentali al Ago 14, 2026

CRIS Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

Prezzo
$1.88
Capitalizzazione di Mercato
$1M
P/E (TTM)
-0.2
EPS (TTM)
$-0.58
Ricavi (TTM)
$9M
Rendimento div.
ROE
177.9%
D/E Debito/Patrimonio
0.0
Intervallo 52 sett.
$0 – $9

CRIS Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Ricavi e Utile Netto $9M
10-point trend, +25.5%
2016-12-31 2025-12-31
EPS $-0.58
7-point trend, +40.2%
2019-12-31 2025-12-31
Flusso di cassa libero
7-point trend, -6.3%
2016-12-31 2023-12-31
Margini -80.3%

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica
Tendenza 5 anni
CRIS
Mediana dei peer
P/E (TTM)
5-point trend, -100.9%
-0.2
P/S (TTM)
5-point trend, -99.9%
0.1
2.9
P/B
5-point trend, -98.0%
0.2
1.1
EV / EBITDA
5-point trend, +97.0%
0.7

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica
Tendenza 5 anni
CRIS
Mediana dei peer
Operating Margin (Margine Operativo)
5-point trend, +73.7%
-60.5%
Net Profit Margin (Margine di Profitto Netto)
5-point trend, +70.9%
-80.3%
-4409.1%
ROA
5-point trend, +0.8%
-24.8%
-111.4%
ROE
5-point trend, +403.5%
177.9%
-169.4%

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica
Tendenza 5 anni
CRIS
Mediana dei peer
Debt / Equity (Debito / Patrimonio Netto)
5-point trend, +0.00
0.0
0.0
Current Ratio (Rapporto corrente)
5-point trend, -97.1%
0.5
1.9
Quick Ratio
5-point trend, -97.9%
0.4

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica
Tendenza 5 anni
CRIS
Mediana dei peer
Revenue YoY (Ricavi YoY)
5-point trend, -11.3%
-13.4%
Revenue CAGR 3Y (CAGR Ricavi 3Y)
5-point trend, -11.3%
-2.4%
Revenue CAGR 5Y (CAGR Ricavi 5Y)
5-point trend, -11.3%
-2.7%

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica
Tendenza 5 anni
CRIS
Mediana dei peer
EPS (Diluted) (EPS (Diluito))
5-point trend, -216.0%
$-0.58

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica
Tendenza 5 anni
CRIS
Mediana dei peer

CRIS Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

COMPRA 10 analisti
  • Acquisto forte 2 20,0%
  • Compra 7 70,0%
  • Mantieni 1 10,0%
  • Vendi 0 0,0%
  • Vendita forte 0 0,0%

Target Price a 12 Mesi

3 analisti · 2026-08-16
Target mediano $43.00 +2187,2%
Target medio $42.67 +2169,5%

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Sorpresa media
-1.8%
Periodo EPS Actual EPS Stimato Sorpresa
31 Marzo 2026 $-25.00 $-8.16 -16.8%
31 Dicembre 2025 $-10.00 $-9.18 -0.82%
30 Settembre 2025 $-9.80 $-11.79 2.0%
30 Giugno 2025 $-13.60 $-18.16 4.6%
31 Marzo 2025 $-1.25 $-1.21 -0.04%
31 Dicembre 2024 $-1.25 $-1.39 0.14%

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

Ticker Capitalizzazione di Mercato P/E Rev YoY Margine Netto ROE Margine lordo
CRIS $13M -1.7 -13.4% -80.3% 177.9%
HCWB -0.1 -97.9% -14677.1% -586.8% 20.0%
REVB
SILO $5M -0.7 0.00% -5863.5% -75.3% 38.6%
VIVS $4M -0.3 -9.0% -10567.2% -294.8%
RNAZ -0.1
ONCO $2M -0.1 -67.7% -1721.0% -129.5% 77.6%
BIAF

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Conto Economico 15
Dati annuali Conto Economico per CRIS
Metrica Tendenza 202520242023202220212020201920182017201620152014
Revenue 12-point trend, -4.1% $9M $11M $10M $10M $11M $11M $10M $10M $10M $8M $8M $10M
R&D Expense 2-point trend, +31.8% · · · · · · · · · $18M · $14M
SG&A Expense 12-point trend, +20.0% $14M $17M $19M $20M $17M $12M $12M $15M $14M $16M $13M $12M
Operating Expenses 12-point trend, +64.7% $42M $55M $58M $63M $53M $36M $34M $40M $60M $66M $64M $26M
Operating Income 12-point trend, +64.0% $-6M $-45M $-48M $-53M $-42M $-25M $-24M $-29M $-50M $-58M $-56M $-16M
Interest Expense 8-point trend, -100.0% · · · · $0 $0 $791.0K $4M $4M $3M $3M $4M
Interest Income 12-point trend, +91.5% $316.0K $2M $3M $1M $211.0K $63.0K $614.0K $684.0K $513.0K $406.0K $277.0K $165.0K
Other Non-op 12-point trend, +34.8% $-2M $1M $919.0K $-4M $890.0K $22.0K $-58.0K $0 $-4M $-2M $-2M $-3M
Income Tax Flat — no change across 2 periods $0 $0 · · · · · · · · · ·
Net Income 12-point trend, +59.5% $-8M $-43M $-47M $-57M $-45M $-30M $-32M $-33M $-53M $-60M $-59M $-19M
EPS (Basic) 7-point trend, +40.2% $-0.58 $-6.88 $-8.96 $-12.14 $0.50 $-0.61 $-0.97 · · · · ·
EPS (Diluted) 7-point trend, +40.2% $-0.58 $-6.88 $-8.96 $-12.14 $0.50 $-0.61 $-0.97 · · · · ·
Shares (Basic) 7-point trend, -60.3% 13,164,032 6,306,284 5,293,294 4,669,626 91,569,154 48,670,381 33,180,516 · · · · ·
Shares (Diluted) 7-point trend, -60.3% 13,164,032 6,306,284 5,293,294 4,669,626 91,569,154 48,670,381 33,180,516 · · · · ·
EBITDA 11-point trend, +64.0% $-6M $-45M $-48M · $-42M $-25M $-24M $-29M $-50M $-58M $-56M $-16M
Stato Patrimoniale 27
Dati annuali Stato Patrimoniale per CRIS
Metrica Tendenza 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, -34.7% $5M $20M $27M $20M $40M $130M $15M $24M $38M $26M $33M $8M
Short-term Investments 11-point trend, -100.0% · $0 $30M $66M $76M $39M $5M $634.0K $22M $18M $49M $42M
Receivables 12-point trend, -100.0% $0 $3M $3M $3M $3M $3M $3M $3M $3M $2M $2M $2M
Prepaid Expense 12-point trend, +278.5% $2M $3M $2M $4M $3M $1M $1M $827.0K $989.0K $1M $1M $489.8K
Current Assets 12-point trend, -86.8% $7M $26M $61M $92M $122M $173M $25M $28M $64M $48M $86M $52M
PP&E (Net) 12-point trend, -84.8% $62.0K $231.0K $434.0K $689.0K $505.0K $663.0K $154.0K $267.0K $400.0K $400.0K $300.0K $407.7K
PP&E (Gross) 12-point trend, -60.9% $913.0K $1M $2M $3M $3M $3M $2M $2M $2M $2M $2M $2M
Accum. Depreciation 12-point trend, -55.9% $851.0K $1M $2M $2M $2M $2M $2M $2M $2M $2M $2M $2M
Goodwill 12-point trend, +0.0% $9M $9M $9M $9M $9M $9M $9M $9M $9M $9M $9M $9M
Other Non-current Assets 12-point trend, +2228.9% $2M $2M $3M $2M $0 $3.0K $3.0K $2.0K $3.0K $3.0K $51.0K $67.5K
Total Assets 12-point trend, -68.1% $20M $41M $77M $109M $162M $204M $35M $37M $74M $58M $95M $63M
Accounts Payable 12-point trend, +138.9% $6M $3M $3M $3M $6M $4M $4M $3M $5M $6M $4M $2M
Accrued Liabilities 12-point trend, +262.3% $7M $7M $9M $6M $6M $4M $2M $3M $3M $3M $2M $2M
Current Liabilities 12-point trend, +39.8% $14M $19M $22M $10M $13M $10M $7M $13M $14M $14M $11M $10M
Capital Leases 7-point trend, +428000.00 $428.0K $2M $1M $3M $4M $5M $0 · · · · ·
Other Non-current Liabilities 8-point trend, -100.0% · · · · $0 $334.0K $0 $11.0K $34.0K $18.0K $139.0K $174.0K
Total Liabilities 12-point trend, -55.8% $15M $47M $58M $62M $72M $74M $69M $42M $50M $28M $30M $33M
Long-term Debt 7-point trend, -96.9% · · · · · $891.0K $0 $35M $42M $20M $24M $28M
Total Debt 10-point trend, -100.0% $0 $8M · · $0 $557.0K $0 $35M $42M $20M $24M $28M
Common Stock 12-point trend, -99.3% $6.0K $85.0K $59.0K $48.0K $916.0K $915.0K $332.0K $332.0K $331.0K $1M $1M $872.5K
Paid-in Capital · · · · · · · · · · · $810M
Retained Earnings 12-point trend, -60.0% $-1.25B $-1.24B $-1.20B $-1.15B $-1.09B $-1.05B $-1.02B $-985M $-952M $-899M $-839M $-780M
Treasury Stock 5-point trend, -100.0% · · · · · · · $0 $2M $2M $2M $2M
AOCI 11-point trend, +100.0% · $0 $229.0K $-186.0K $-109.0K $-3.0K $0 $0 $-2.0K $-4.0K $28.0K $-11.0K
Stockholders' Equity 12-point trend, -81.7% $5M $-6M $20M $47M $91M $131M $-34M $-4M $24M $29M $65M $30M
Liabilities + Equity 12-point trend, -68.1% $20M $41M $77M $109M $162M $204M $35M $37M $74M $58M $95M $63M
Shares Outstanding 12-point trend, -99.2% 646,537 8,487,818 5,894,085 4,830,464 91,645,369 91,502,461 33,241,793 33,159,253 32,831,380 141,124,025 128,990,378 86,030,811
Flusso di cassa 10
Dati annuali Flusso di cassa per CRIS
Metrica Tendenza 202520242023202220212020201920182017201620152014
D&A 12-point trend, -15.5% $169.0K $203.0K $255.0K $233.0K $158.0K $144.0K $125.0K $177.0K $235.0K $193.0K $200.0K $200.0K
Stock-based Comp 12-point trend, +31.3% $4M $6M $6M $7M $5M $3M $3M $4M $5M $4M $4M $3M
Operating Cash Flow 12-point trend, -61.8% $-27M $-40M $-38M $-54M $-38M $-26M $-26M $-30M $-48M $-36M $-30M $-17M
CapEx 10-point trend, -100.0% · · $0 $416.0K $0 $677.0K $41.0K $85.0K $188.0K $329.0K $48.0K $92.0K
Investing Cash Flow 12-point trend, -84.6% $2M $29M $38M $33M $-48M $-49M $-4M $21M $-4M $30M $-6M $16M
Stock Issued 12-point trend, +15352000.00 $15M $12M $14M $6M $0 $159M $0 $0 $42M $0 $65M $0
Net Stock Activity 10-point trend, +5328.6% $15M $12M $14M · $0 $159M · $0 $42M $0 $65M $282.8K
Financing Cash Flow 12-point trend, +848.8% $10M $3M $8M $867.0K $-4M $189M $23M $-6M $64M $-1M $62M $-1M
Net Change in Cash 12-point trend, -710.0% $-15M $-7M $7M $-20M $-90M $114M $-7M $-15M $12M $-7M $25M $-2M
Free Cash Flow 9-point trend, -127.4% · · $-38M · $-38M $-26M $-26M $-30M $-49M $-36M $-30M $-17M
Redditività 5
Dati annuali Redditività per CRIS
Metrica Tendenza 202520242023202220212020201920182017201620152014
Operating Margin 11-point trend, +62.5% -60.5% -408.3% -482.2% · -395.0% -229.8% -243.5% -281.3% -502.7% -771.1% -716.9% -161.1%
Net Margin 11-point trend, +57.8% -80.3% -397.8% -473.0% · -426.7% -276.0% -320.9% -312.6% -538.7% -802.6% -748.6% -190.3%
EBITDA Margin 11-point trend, +62.5% -60.5% -408.3% -482.2% · -395.0% -229.8% -243.5% -281.3% -502.7% -771.1% -716.9% -161.1%
ROA 11-point trend, +5.3% -24.8% -73.2% -50.9% · -24.8% -25.0% -88.6% -58.7% -81.1% -79.1% -74.9% -26.2%
ROE 11-point trend, +456.0% 177.9% 589.0% -192.5% · -46.9% -58.6% 107.1% 1755.5% -199.5% -128.8% -125.1% -50.0%
Liquidità e Solvibilità 5
Dati annuali Liquidità e Solvibilità per CRIS
Metrica Tendenza 202520242023202220212020201920182017201620152014
Current Ratio 11-point trend, -90.5% 0.5 1.4 4.5 · 9.1 17.1 3.8 2.1 4.6 3.6 7.9 5.2
Quick Ratio 11-point trend, -93.0% 0.4 1.2 4.4 · 8.9 17.0 3.6 2.0 4.5 3.5 7.8 5.1
Debt / Equity 10-point trend, -100.0% 0.0 -1.3 · · 0.0 0.0 0.0 -7.9 1.7 0.7 0.4 1.0
LT Debt / Equity 6-point trend, -100.0% · · · · · · 0.0 -6.4 1.5 0.5 0.3 0.8
Interest Coverage 6-point trend, -627.6% · · · · · · -30.8 -7.5 -12.5 -20.9 -17.0 -4.2
Efficienza 2
Dati annuali Efficienza per CRIS
Metrica Tendenza 202520242023202220212020201920182017201620152014
Asset Turnover 11-point trend, +124.3% 0.3 0.2 0.1 · 0.1 0.1 0.3 0.2 0.2 0.1 0.1 0.1
Receivables Turnover 11-point trend, -1.5% 5.6 3.6 3.5 · 3.4 3.4 3.3 3.5 3.6 3.3 3.9 5.7
Per Azione 5
Dati annuali Per Azione per CRIS
Metrica Tendenza 202520242023202220212020201920182017201620152014
Book Value / Share 11-point trend, +22.0% $0.42 $-0.71 $3.34 · $0.99 $1.43 $-1.02 $-0.14 $0.15 $0.21 $0.50 $0.35
Revenue / Share 4-point trend, +516.8% $0.72 $1.73 $1.89 · $0.12 · · · · · · ·
Cash Flow / Share 4-point trend, -403.0% $-2.07 $-6.27 $-7.26 · $-0.41 · · · · · · ·
Cash / Share 11-point trend, +334.5% $0.39 $2.36 $4.53 · $0.44 $1.42 $0.46 $0.71 $0.23 $0.18 $0.26 $0.09
EPS (TTM) 7-point trend, +40.2% $-0.58 $-6.88 $-8.96 $-12.14 $0.50 $-0.61 $-0.97 · · · · ·
Tassi di Crescita 3
Dati annuali Tassi di Crescita per CRIS
Metrica Tendenza 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, -680.8% -13.4% 8.8% -1.4% -4.6% -1.7% · · · · · · ·
Revenue CAGR 3Y 3-point trend, +5.5% -2.4% 0.80% -2.6% · · · · · · · · ·
Revenue CAGR 5Y -2.7% · · · · · · · · · · ·
Valutazione (TTM) 14
Dati annuali Valutazione (TTM) per CRIS
Metrica Tendenza 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, -4.1% $9M $11M $10M $10M $11M $11M $10M $10M $10M $8M $8M $10M
Net Income TTM 12-point trend, +59.5% $-8M $-43M $-47M $-57M $-45M $-30M $-32M $-33M $-53M $-60M $-59M $-19M
Market Cap 11-point trend, -99.9% $13M $26M $75M · $8.72B $14.99B $1.13B $458M $11.49B $43.47B $37.54B $12.90B
Enterprise Value 10-point trend, -99.9% $8M $14M · · $8.61B $14.82B $1.11B $469M $11.47B $43.44B $37.48B $12.88B
P/E 7-point trend, +95.1% -1.7 -0.4 -1.4 -0.9 190.4 -268.5 -35.1 · · · · ·
P/S 11-point trend, -99.9% 1.4 2.4 7.5 · 819.3 1383.3 113.0 43.9 1160.9 5774.7 4764.7 1311.0
P/B 11-point trend, -99.5% 2.3 -4.3 3.8 · 96.2 114.7 -33.3 -101.8 478.9 1485.2 581.9 433.3
P / Tangible Book 4-point trend, -94.3% · · 7.0 28.3 106.8 123.2 · · · · · ·
P / Cash Flow 11-point trend, +99.9% -0.5 -0.7 -2.0 · -231.9 -582.3 -43.1 -15.2 -237.6 -1213.8 -1255.8 -767.5
P / FCF 9-point trend, +99.7% · · -2.0 · -231.9 -567.4 -43.1 -15.2 -236.7 -1202.7 -1253.8 -763.4
EV / EBITDA 10-point trend, +99.8% -1.4 -0.3 · · -204.7 -595.2 -45.6 -16.0 -230.6 -748.5 -663.6 -812.2
EV / FCF 8-point trend, +70.0% · · · · -228.8 -561.0 -42.3 -15.5 -236.3 -1202.0 -1251.8 -762.1
EV / Revenue 10-point trend, -99.9% 0.8 1.2 · · 808.4 1367.8 110.9 45.0 1159.1 5771.4 4757.3 1308.9
Earnings Yield 7-point trend, -1955.8% -58.6% -224.8% -70.3% -110.4% 0.53% -0.37% -2.9% · · · · ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Conto Economico
2025-12-312024-12-312023-12-312022-12-312021-12-31
Ricavi $9M$11M$10M$10M$11M
Margine Operativo % -60.5%-408.3%-482.2%-395.0%
Utile netto $-8M$-43M$-47M$-57M$-45M
EPS Diluito $-0.58$-6.88$-8.96$-12.14$0.50
Stato Patrimoniale
2025-12-312024-12-312023-12-312022-12-312021-12-31
Debito / Patrimonio Netto 0.0-1.30.0
Rapporto corrente 0.51.44.59.1
Quick Ratio 0.41.24.48.9
Flusso di cassa
2025-12-312024-12-312023-12-312022-12-312021-12-31
Flusso di cassa libero $-38M$-38M

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

📊

Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

Proprietari istituzionali (13F) 39 filer · $7.0M totale · Aggiornato al 30 Giugno 2026

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Attività istituzionale — Q2 2026 vs trimestre precedente
Nuove posizioni Posizioni chiuse Aumentato Diminuito Variazione netta delle azioni
9 (+1 vs trimestre precedente) 12 (+4 vs trimestre precedente) 5 (-8 vs trimestre precedente) 7 (+1 vs trimestre precedente) -3.9M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione Valore Azioni % di 13F tracciati Tipo
Bleichroeder LP $1.985.196 3.802.329 28,49% Azioni
Stonepine Capital Management, LLC $1.729.292 3.312.185 24,82% Azioni
SPHERA FUNDS MANAGEMENT LTD. $1.033.717 98.996 14,84% Azioni
Cable Car Capital, LP $696.134 1.333.334 9,99% Azioni
CM Management, LLC $287.155 550.000 4,12% Azioni
MORGAN STANLEY $263.290 504.291 3,78% Azioni
VANGUARD CAPITAL MANAGEMENT LLC $179.486 343.842 2,58% Azioni
M28 Capital Management LP $148.741 284.889 2,13% Azioni
GEODE CAPITAL MANAGEMENT, LLC $142.044 272.044 2,04% Azioni
FLPUTNAM INVESTMENT MANAGEMENT CO $128.306 245.750 1,84% Azioni
RENAISSANCE TECHNOLOGIES LLC $74.123 141.972 1,06% Azioni
VANGUARD GROUP INC $60.862 61.664 0,87% Azioni
XTX Topco Ltd $56.470 108.160 0,81% Azioni
NORTHERN TRUST CORP $50.054 95.870 0,72% Azioni
VANGUARD FIDUCIARY TRUST CO $32.189 61.664 0,46% Azioni
BlackRock, Inc. $27.846 53.334 0,40% Azioni
Focused Wealth Management, Inc $26.131 50.049 0,38% Azioni
STATE STREET CORP $10.990 21.049 0,16% Azioni
FRANKLIN STREET ADVISORS INC /NC $10.442 20.000 0,15% Azioni
LPL Financial LLC $7.819 14.977 0,11% Azioni
MAVERICK CAPITAL LTD $6.194 49.554 0,09% Azioni
Dauntless Investment Group, LLC $5.222 10.001 0,07% Azioni
BARCLAYS PLC $3.641 6.973 0,05% Azioni
Steward Partners Investment Advisory, LLC $1.356 2.597 0,02% Azioni
OSAIC HOLDINGS, INC. $785 1.510 0,01% Azioni
GROUP ONE TRADING LLC $235 450 0,00% Azioni
Axiom Investment Management LLC $52 100 0,00% Azioni
JPMORGAN CHASE & CO $48 108 0,00% Azioni
JONES FINANCIAL COMPANIES LLLP $39 120 0,00% Azioni
WELLS FARGO & COMPANY/MN $29 55 0,00% Azioni
CWM, LLC $28 51 0,00% Azioni
UBS Group AG $16 31 0,00% Azioni
GSA CAPITAL PARTNERS LLP $12 22.760 0,00% Azioni
CIBC Private Wealth Group LLC $10 6 0,00% Azioni
WR Wealth Planners, LLC $3 1 0,00% Azioni
Blue Trust, Inc. $2 4 0,00% Azioni
VIMA LLC $2 3 0,00% Azioni
MPWM ADVISORY SOLUTIONS, LLC $1 2 0,00% Azioni
ROYAL BANK OF CANADA $0 63 0,00% Azioni

Insider aziendali 33 insider · 17 dirigenti · 16 direttori

Insider Ruolo Ultima attività Azioni possedute Acquisti 12m Vendite 12m Netto 12m
James E Dentzer President & CEO 07 Luglio 2026 A 148.730 0 0 $0
Ali Fattaey Ph.D. President & CEO 15 Maggio 2018 A 322.140 0 0 $0
Diantha Duvall CFO 07 Luglio 2026 A 77.707 0 0 $0
William Steinkrauss Chief Financial Officer 29 Gennaio 2022 A 0 0 $0
Michael Gray CFO 27 Maggio 2015 A 107.304 0 0 $0
Mitchell Keegan Vice-President 07 Gennaio 2011 A 0 0 $0
Jonathan B. Zung CDO 07 Luglio 2026 A 66.667 0 0 $0
Ahmed Hamdy MD CMO 20 Marzo 2026 C 66.667 0 0 $0
Robert Martell Head of Research & Development 20 Gennaio 2023 A 23.027 0 0 $0
David Tuck Chief Medical Officer 15 Maggio 2018 A 169.424 0 0 $0
Mani Mohindru Chief Strategy Officer 14 Febbraio 2017 A 0 0 $0
Jaye Viner Chief Medical Officer 27 Maggio 2015 A 0 0 $0
Mark Noel VP, Tech Management 02 Maggio 2013 M 27.540 0 0 $0
Changgeng Qian VP, Research & Preclinical Dev 07 Gennaio 2011 A 0 0 $0
Mary Elizabeth Potthoff VP and General Counsel 31 Maggio 2006 A 0 0 0 $0
Lee L Rubin VP of Research 01 Giugno 2005 A 9.814 0 0 $0
Christopher U Missling Sr. VP, Strategic Planning 16 Gennaio 2004 M 0 0 0 $0
Anne Elizabeth Borgman Direttore 07 Luglio 2026 A 0 0 $0
John Hohneker Direttore 07 Luglio 2026 A 0 0 $0
Marc Rubin Direttore 07 Luglio 2026 A 28.108 0 0 $0
Kenneth I Kaitin Direttore 07 Luglio 2026 A 11.407 1 0 $5.500
Martyn D Greenacre Direttore 07 Luglio 2026 A 26.089 0 0 $0
Lori Anne Kunkel Direttore 31 Gennaio 2022 A 22.200 0 0 $0
James R Mcnab Direttore 05 Maggio 2017 S 50.000 0 0 $0
Kenneth Pienta Direttore 28 Febbraio 2017 A 30.000 0 0 $0
James R Tobin Direttore 26 Gennaio 2015 A 144.921 0 0 $0
Susan B Bayh Direttore 17 Gennaio 2013 A 25.000 0 0 $0
Joseph Davie MD PHD Direttore 07 Gennaio 2011 A 0 0 $0
Stephen Carter Direttore 25 Gennaio 2008 A 0 0 $0
Joseph M Davie Direttore 06 Giugno 2007 A 20.000 0 0 $0
Douglas Melton Direttore 23 Agosto 2006 A 173.499 0 0 $0
Daniel R Passeri 19 Gennaio 2016 A 211.798 0 0 $0
Maurizio Voi 17 Gennaio 2013 A 0 0 $0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Attivisti e proprietari del 5%+ 3 partecipazioni

Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.

Depositante Depositato Partecipazione Stato Scopo Deposito
Persona segnalante non divulgata 04 Marzo 2004 Deposito iniziale SEC
Persona segnalante non divulgata 29 Gennaio 2004 Deposito iniziale Investimento passivo SEC
Persona segnalante non divulgata 04 Giugno 2003 Deposito iniziale SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Proprietà ETF Posseduti da 2 ETF

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo Peso Unità Aggiornato al Fonte
VXF · VANGUARD INDEX FUNDS 0,00% 128.243 SH 08 Agosto 2026 Giornaliero
VTI · VANGUARD INDEX FUNDS 0,00% 215.599 SH 08 Agosto 2026 Giornaliero